In this study, 46 carcinomas showed EGFR gene amplification, which include 42 tumors (30.2%) presenting high polysomy and 4 tumors (2.9%) presenting amplification (based on the ratio of EGFR gene copies to CEP7 gene copies in at least 100 tumor cell nuclei). The gene discussed is EGFR; the disease is carcinoma.